Advertisement ICON Q2 revenue rises - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ICON Q2 revenue rises

ICON, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has reported net revenue of $233.04m for the fiscal second quarter ended 30 June 2011, an increase of 4.2%, compared to $223.75m for the same period in 2010.

For the second quarter of 2011, the company has generated net income of $13.08m, compared to $22.87m for the same period in 2010.

ICON’s income from operations was $15.51m, compared to $25.68m for the same period last year.

For the six months ended 30 June 2011, the company posted net revenue of $462.34m, compared to $442.86m for the same period in 2010.

Net income was $25.89m for the six months of 2011 compared to $45.07m in the prior year period.

The company’s income from operations was $31.48m, compared to $52.46m for the same period in 2010.